ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHAGENCY FOR HEALTHCARE RESEARCH AND QUALITYR01

Adapting and Implementing Risk-Stratified Penicillin Allergy Evaluation in Key Outpatient Settings

Active
Institution
Vanderbilt University Medical Center, TN
Principal investigator
Cosby A Stone
Funding
$483K
Duration
2024–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Untested penicillin allergies, or “labels”, are highly prevalent, and they adversely impact healthcare quality by limiting use of guideline-recommended first-line antibiotics, thereby increasing treatment failures, drug resistance, and opportunistic infections. 10-15% of the US population carries a penicillin allergy label (PAL), but only 1 in 20 of PALs are verified as accurate after allergy testing. In previous work we developed, validated, and implemented risk-stratified management for low-risk penicillin allergy delabeling at our institution 99% NPV (95%CI 96.4, 99.9) with more than 400 patients delabeled by non-allergists to date. We now seek to extend this work using the ADAPT-ITT framework with an impact on outpatient antimicrobial stewardship by 1. measuring efficacy, barriers and facilitators of outpatient antibiotic allergy assessment for surgical, transplant and obstetric patients, 2. designing and piloting patient-centered penicillin allergy self-assessments, and 3. implementing penicillin allergy assessment in the outpatient pre-surgical environment. We hypothesize that 1. There may be additional barriers and adaptations to implement penicillin allergy risk assessment and challenges across different settings that can be overcome, leading to a model for optimal outpatient implementation of penicillin allergy risk assessment 2. That a patient performed risk-stratification questionnaire is sufficient to identify low-risk penicillin allergies and impact obstetric referrals for testing, and 3. That routinely performed penicillin allergy risk assessment will improve use of first line surgical prophylaxis. Completion of these proposed research aims would create new tools for penicillin allergy assessment delabeling efforts, new models for optimal implementation in the outpatient setting, and augment our platform for delivering drug allergy services at the points of care where they are needed most. Our multidisciplinary team is uniquely positioned to ensure the success of this undertaking.

LOADING MOONBASE SCORE

R01AGENCY FOR HEALTHCARE RESEARCH AND QUALITYHealthcare Patient Safety and Quality Improvement Research[HSQR]allergiesassessmentpenicillinoutpatientallergyrisk assessmentobstetriclow-risk

Questions for Vanderbilt University Medical Center

Answered by the team behind this research.

Same institution, same topic, scored first.